Clinical Trial Update: Alternative Dosing Strategy for Anti-HIV Drugs [Phase 4]

View source ↗

Summary

Phase 4 trial results examining alternative dosing strategies for anti-HIV medications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 4 | Status: COMPLETED